Lv4
470 积分 2024-12-02 加入
P2.06.100 Initial Biomarker Results From the Phase 2A Study of AFM24 With Atezolizumab in Patients With Advanced/Metastatic NSCLC
4个月前
已关闭
Report of the 2003 Pan-Canadian Forum on Cervical Cancer Prevention and Control
4个月前
已完结
An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer
4个月前
已完结
皖公网安备34019202002308
